Skye Bioscience, Inc.
SKYE
$1.91
$0.094.95%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5,344.94% | 1,215.06% | 8,761.90% | 2,728.01% | -4.71% |
| Total Receivables | -98.11% | -- | -26.60% | 322.26% | 288.87% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.96% | 220.75% | 305.18% | -33.11% | -75.12% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -76.88% | 17.74% | 29,244.39% | 2,311.02% | 42.56% |
| Total Current Assets | 507.92% | 422.09% | 4,496.85% | 2,024.74% | 30.27% |
|
|
|||||
| Total Current Assets | 507.92% | 422.09% | 4,496.85% | 2,024.74% | 30.27% |
| Net Property, Plant & Equipment | 569.25% | 449.10% | -25.71% | 101.17% | 76.92% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 549.40% | 216.87% | 0.00% | 0.00% | 0.00% |
| Total Assets | 509.39% | 422.52% | 3,802.75% | 1,967.52% | 31.05% |
|
|
|||||
| Total Accounts Payable | -40.50% | -52.19% | -30.42% | -10.54% | -46.69% |
| Total Accrued Expenses | -14.15% | 108.93% | 33.72% | 145.92% | 84.33% |
| Short-term Debt | -- | -- | 5,263.69% | 2,806.18% | 7,777.48% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 153.33% | 20.67% | 20.92% | -7.13% | -96.26% |
| Total Finance Division Other Current Liabilities | -71.76% | -72.13% | -5.79% | -2.58% | -10.85% |
| Total Other Current Liabilities | -71.76% | -72.13% | -5.79% | -2.58% | -10.85% |
| Total Current Liabilities | -68.79% | -59.00% | 45.90% | 68.68% | 14.70% |
|
|
|||||
| Total Current Liabilities | -68.79% | -59.00% | 45.90% | 68.68% | 14.70% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | 5,263.69% | 2,806.18% | 7,777.48% |
| Capital Leases | 59.58% | -43.25% | -37.73% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -67.23% | -58.79% | 44.16% | 70.29% | 16.12% |
|
|
|||||
| Common Stock & APIC | 94.72% | 93.79% | 182.79% | 180.50% | 60.44% |
| Retained Earnings | -25.45% | -21.25% | -56.37% | -52.15% | -56.41% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 3,296.91% | 4,371.39% | 1,034.74% | 1,750.07% | 29.13% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3,296.91% | 4,371.39% | 1,034.74% | 1,750.07% | 29.13% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3,296.91% | 4,371.39% | 1,034.74% | 1,750.07% | 29.13% |
|
|
|||||